Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 43 clinical trials
A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast (COC-IDCB)

, Epirubicin, Fluorouracil and Methotrexate (CDEFM), in the format of either a single agent or combinations are safe, tolerable, and effective in the treatment of patients with infiltrating ductal carcinoma of

epirubicin
doxorubicin
antineoplastic
cyclophosphamide
breast carcinoma
  • 1 views
  • 16 May, 2022
  • 3 locations
A Phase Study of Anlotinib Combined With Tislelizumab and AT in the Neoadjuvant Treatment of Triple-negative Breast Cancer

Epirubicin+albumin-bound paclitaxelregimen, followed by surgery.

metastasis
epirubicin
growth factor
paclitaxel
  • 0 views
  • 28 Jul, 2021
  • 1 location
Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer

epirubicin, fluorouracil and cisplatin (or oxaliplatin) are widely used in Europe. However, traditional anthracyclines are more cardiotoxic; and (Pegliposomal Doxorubicin) PLD, as a new liposome dosage form

neutrophil count
solid tumor
metastatic gastric cancer
epirubicin
fluorouracil
  • 0 views
  • 24 Jan, 2021
  • 1 location
Pyrotinib in Combination With Neoadjuvant Chemotherapy in HR+/HER2- HER4 High Expression Breast Cancer Patients: A Phase II Trial

This is a Phase II, single-center, double-blind, placebo-controlled, randomized study of Pyrotinib in combination with Doxorubicin/Epirubicin and Cyclophosphamide followed by Docetaxel/nab

  • 0 views
  • 12 May, 2021
  • 1 location
Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer

. More than 80% of women of childbearing age, treated for breast cancer with standard protocol of neoadjuvant (4 cycles of 5-fluorouracile - epirubicin- cyclophosphamide (FEC) and 4 cycles of docetaxel

  • 0 views
  • 29 Apr, 2021
  • 1 location
MicroRNA Profiles in Triple Negative Breast Cancer (TARMAC)

chemotherapy using Epirubicin (60mg/m2), Cyclophosphamide (600mg/m2) , Paclitaxel (120mg/m2) and Carboplatin (6AUC) in TNBC patients. We will measure the blood level of microRNA molecules and circulating tumor

triple negative breast cancer
epirubicin
taxane
doxorubicin
erbb2
  • 0 views
  • 23 Mar, 2022
  • 1 location
Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas (ImmunoSarc)

, non-compliance, withdrawal of consent by the patient or investigator decision. C 7 Objective: To determine the MTD of the epirubicin + ifosfamide + nivolumab combination in

calcium
extraskeletal myxoid chondrosarcoma
immunomodulators
measurable disease
doxorubicin
  • 94 views
  • 25 Feb, 2022
  • 13 locations
Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer

The study assesses the efficacy of neoadjuvant treatment with pyrotinib and trastuzumab with chemotherapy, mainly pathological complete response (pCR) rates in the breast and axilla. And also assesses side effects, event-free survival (EFS), disease-free survival (DFS), distant disease-free survival (DDFS), and objective response rates (ORR).

trastuzumab
invasive breast cancer
epidermal growth factor receptor
epirubicin
docetaxel
  • 0 views
  • 14 Jun, 2021
  • 1 location
Zanubrutinib Combined With R-CHOP in Newly-diagnosed Intravascular Large B-cell Lymphoma

This is a prospective single-arm phase II study, and the purpose of this study is to evaluate the efficiency of zanubrutinib combined with R-CHOP regimen in newly diagnosed primary intraocular lymphoma. Progression-free survival (PFS) of the cohort is the primary endpoint.

  • 0 views
  • 04 Jun, 2021
  • 1 location
Single-arm Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast Cancer

This study aimed to evaluate the Pyrotinib in combination with albumin-bound paclitaxel and trastuzumab to neoadjuvant therapy efficacy and safety of Her2-positive early or locally advanced breast cancer

advanced breast cancer
immunohistochemistry
trastuzumab
her2/neu-positive breast cancer
measurable disease
  • 0 views
  • 27 Sep, 2021
  • 1 location